⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tki 258

Every month we try and update this database with for tki 258 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNCT01379534
Solid Tumors an...
Endometrial Can...
Second-line Tre...
VEGF
TKI258
18 Years - Novartis
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsNCT01576380
Adenocarcinoma,...
Linitis Plastic...
Stomach Neoplas...
Stomach Disease...
Neoplasms by Si...
Neoplasms
TKI258
20 Years - Novartis
Safety of CHIR-258 (TKI258) in Advanced Solid TumorsNCT01270906
Neoplasms
Cancer
Tumors
CHIR-258 (TKI25...
18 Years - Novartis
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsNCT01576380
Adenocarcinoma,...
Linitis Plastic...
Stomach Neoplas...
Stomach Disease...
Neoplasms by Si...
Neoplasms
TKI258
20 Years - Novartis
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNCT01379534
Solid Tumors an...
Endometrial Can...
Second-line Tre...
VEGF
TKI258
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: